search
free newslett
subscrib
headlin
ingredi
drug deliveri
process
regulatori safeti
promot featur
site archiv
multimedia
hot topic
challeng
globalis
lifecycl manag
merger acquisit
site archiv
multimedia
resourc
resourc
event
event
onlin event
editori webinar
show confer
event
relat site
dan
mar2014
last updat
mar2014 gmt
relat tag
import alert sun pharma pharmaceut drug food drug administr fda
facil karkhadi gujarat produc cephalosporin class βlactam antibiot file bombay stock exchang thi morn sun pharmaceut industri announc unit place import alert us food drug administr fda
alert wa issu follow inspect us agenc identifi noncompli current good manufactur practic cgmp regul thu drug made facil may detain without physic examin time fda satisfi appear violat ha remov either reinspect submiss appropri document respons fda center
sun pharma spokesperson mira desai told inpharmatechnologistcom alert ha neglig impact companywid revenu would unlik caus ani shortag us
furthermor confirm firm ha alreadi initi sever correct step address observ made fda wa unabl provid detail
share firm fell 5 follow announc
import alert india
news see sun pharma join grow list high profil indian drugmak product head us ban due gmp violat
four ranbaxi facil india subject alert api plant toansa becom latest fall ban januari whilst two wockhardt facil fell import ban last year
googletagcmdpushfunct
fda ha spoken length ensur qualiti indian supplier commission margaret hamburg visit countri last month part address thi issu statement intent wa sign pledg cooper ensur complianc us indian author fda ha also said would number inspector countri
thi specif import alert 6640 cite 33 facil india product import ban howev whilst much recent emphasi ha india 31 facil china also affect ban next largest countri germani eight plant ban export drug us
antibiot produc facil run sun pharma ha hit import alert us fda latest blow indian drug export
facil karkhadi gujarat dedic produc cephalosporin class βlactam antibiot file bombay stock exchang thi morn sun pharmaceut industri announc unit place import alert us food drug administr fda
alert wa issu follow inspect plant agenc identifi noncompli current good manufactur practic cgmp regul thu drug made facil may detain without physic examin time fda satisfi appear violat ha remov either reinspect submiss appropri document respons fda center
sun pharma spokesperson mira desai told inpharmatechnologistcom alert ha neglig impact companywid revenu would unlik caus ani shortag us
furthermor confirm firm ha alreadi initi sever correct step address observ made fda wa unabl provid detail
share firm fell 5 follow announc
import alert india
news see sun pharma join grow list high profil indian drugmak product head us ban due gmp violat
four ranbaxi facil india subject alert api plant toansa becom latest fall ban januari whilst two wockhardt facil fell import ban last year
fda ha spoken length ensur qualiti indian supplier commission margaret hamburg visit countri last month part address thi issu statement intent wa sign pledg cooper ensur complianc us indian author fda ha also said would number inspector countri
thi specif import alert 6640 cite 33 facil india product import ban howev whilst much recent emphasi ha india 31 facil china also affect ban next largest countri germani eight plant ban export drug us
copyright unless otherwis state content thi web site 2018 william reed busi media ltd right reserv full detail use materi thi site found term condit
relat topic
process
api activ pharmaceut ingredi
qaqc
regul
relat topic
process
api activ pharmaceut ingredi
qaqc
regul
show
oct 2018 thursday
germani webinar
pharmaceut compani patient safeti ha alway prioriti whi detect ha becom mandatori qualiti control test
regist free
pharma solut
technic white paper
doe candid take succeed inform need make right decis candid path clinic
technic white paper
tb design function direct compress combin except compress characterist
upcom supplier webinar
promot featur
free newslett
subscrib
sign free newslett get latest news sent direct inbox
